Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Preliminary research shows that taking medication like Zepbound and Wegovy can help patients reduce their risk for dementia ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

A new study from the Department of Veteran Affairs, published in Nature Medicine, found that GLP-1 weight loss drugs including Mounjaro, Ozempic, Wegovy and Zepbound, may offer benefits beyond weight ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.